1. 1. Skinner AC, Ravanbakht SN, Skelton JA, Perrin EM, Armstrong SC. Prevalence of obesity and severe obesity in US children, 1999-2016. Pediatrics. 2018;141(3):1116-23. [DOI:10.1542/peds.2017-3459] [PMID] []

2. Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity among adults and youth: United States, 2015-2016. Nat Center Health Statistics. 2017.;288:1-8.

3. Sarokhani D, Sarokhani M, Dehkordi AH, Gheshlagh RG, Fakhri M. Prevalence of obesity and overweight in Iranian students: a systematic review and meta-analysis. J Pediatr Endocrinol Metab. 2020;33(4):453-68. [DOI:10.1515/jpem-2019-0474] [PMID]

4. Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1• 8 million participants. Lancet (London, England). 2013;383(9921):970-83. [DOI:10.1016/S0140-6736(13)61836-X] [PMID]

5. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev. 1995;75(3):473-86. [DOI:10.1152/physrev.1995.75.3.473] [PMID]

6. Martins LM, Oliveira ARS, Cruz KJC, Torres-Leal FL, Marreiro DdN. Obesity, inflammation, and insulin resistance. Braz J Pharm Sci. 2014;50(4):677-92. [DOI:10.1590/S1984-82502014000400003]

7. Dentali F, Squizzato A, Ageno W, editors. The metabolic syndrome as a risk factor for venous and arterial thrombosis. Seminars in thrombosis and hemostasis; 2009. Thieme Medical Publishers. InSeminars in Thrombosis and Hemostasis. 2009;35(5): 451-7. [DOI:10.1055/s-0029-1234140] [PMID]

8. Vallis M. Quality of life and psychological well‐being in obesity management: improving the odds of success by managing distress. Int J Clin Pract. 2016;70(3):196-205. [DOI:10.1111/ijcp.12765] [PMID] []

9. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;74(10):1376-414. [DOI:10.1016/j.jacc.2019.03.009] [PMID] []

10. Lau DC, Douketis JD, Morrison KM, Hramiak IM, Sharma AM, Ur E. 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ. 2007;176(8):S1-S13. [DOI:10.1503/cmaj.061409] [PMID] []

11. Heymsfield SB, Wadden TA. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376(3):254-66. [DOI:10.1056/NEJMra1514009] [PMID]

12. Chang S-H, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014;149(3):275-87. [DOI:10.1001/jamasurg.2013.3654] [PMID] []

13. Finks JF, English WJ, Carlin AM, Krause KR, Share DA, Banerjee M, et al. Predicting risk for venous thromboembolism with bariatric surgery: results from the Michigan Bariatric Surgery Collaborative. Ann Surg. 2012;255(6):1100-4. [DOI:10.1097/SLA.0b013e31825659d4] [PMID]

14. Pandey A, Thakur B, Hogg F, Brogna C, Logan J, Arya R, et al. The role of preoperative deep vein thrombosis screening in neurooncology. J Neurosurg. 2018;130(1):38-43. [DOI:10.3171/2017.9.JNS17176] [PMID]

15. Winegar DA, Sherif B, Pate V, DeMaria EJ. Venous thromboembolism after bariatric surgery performed by Bariatric Surgery Center of Excellence Participants: analysis of the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis. 2011;7(2):181-8. [DOI:10.1016/j.soard.2010.12.008] [PMID]

16. Kruger PC, Eikelboom JW, Douketis JD, Hankey GJ. Deep vein thrombosis: update on diagnosis and management. Med J Aust. 2019;210(11):516-24. [DOI:10.5694/mja2.50201] [PMID]

17. Cummings DE, Rubino F. Response to Comment on Rubino et al. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. Diabetes Care 2016 [DOI:10.2337/dci16-0031] [PMID]

18. 39: 861-877. Diabetes Care. 2016;39(11):e202-e3. [DOI:10.2337/dci16-0031] [PMID]

19. Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Am J Med. 2005;118(9):978-80. [DOI:10.1016/j.amjmed.2005.03.012] [PMID]

20. Darvall K, Sam R, Silverman S, Bradbury A, Adam D. Obesity and thrombosis. Eur J Vasc Endovasc Surg.2007;33(2):223-33. [DOI:10.1016/j.ejvs.2006.10.006] [PMID]

21. Pannacciulli N, De Mitrio V, Marino R, Giorgino R, De Pergola G. Effect of glucose tolerance status on PAI‐1 plasma levels in overweight and obese subjects. Obes Res. 2002;10(8):717-25. [DOI:10.1038/oby.2002.98] [PMID]

22. Raj PP, Gomes RM, Kumar S, Senthilnathan P, Parathasarathi R, Rajapandian S, et al. Role of routine pre-operative screening venous duplex ultrasound in morbidly obese patients undergoing bariatric surgery. J Minim Access Surg. 2017;13(3):205-7. [DOI:10.4103/jmas.JMAS_199_15] [PMID] []

23. Prystowsky JB, Morasch MD, Eskandari MK, Hungness ES, Nagle AP. Prospective analysis of the incidence of deep venous thrombosis in bariatric surgery patients. Surgery. 2005;138(4):759-65. [DOI:10.1016/j.surg.2005.07.024] [PMID]

24. Bhattacharya S, Kumar SS, Swamy PDK, Palanivelu C, Raj PP. Deep vein thrombosis prophylaxis: Are we overdoing? An Asian survey on trends in bariatric surgery with a systematic review of literature. J Minim Access Surg. 2018;14(4):285-90. [DOI:10.4103/jmas.JMAS_151_17] [PMID] []

25. Abel EJ, Wong K, Sado M, Leverson GE, Patel SR, Downs TM, et al. Surgical operative time increases the risk of deep venous thrombosis and pulmonary embolism in robotic prostatectomy. J Soc Laparoendosc Surg. 2014;18(2):282-7. [DOI:10.4293/JSLS.2014.00101] []